Combodart®

dutasteride/tamsulosin hydrochloride

Combodart product overview

What is Combodart?

Combodart is a fixed dose combination therapy, indicated for the treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH), and the reduction in the risk of acute urinary retention (AUR) and surgery in patients with moderate to severe symptoms of BPH.[1]

In adults (including elderly), the recommended dose of Combodart is one capsule (0.5 mg/ 0.4 mg) once daily.[1]

Expert views

Hear what the experts have to say about importance of combination therapy in BPH patients at risk of progression

Prescribing Combodart

Information on prescribing Combodart including indications and safety information.

References:

  1. Combodart Summary of Product Characteristics. GlaxoSmithKline Jun 15

AB: Last Updated January 2017: MLT_GIB/OTH/0001/15c(1)